Early Breast Cancer Trialists' Collaborative Group

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

Early Breast Cancer Trialists' Collaborative Group, 2008, The Lancet.

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Early Breast Cancer Trialists' Collaborative Group, 1992, Lancet.

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

Early Breast Cancer Trialists' Collaborative Group, 1992, The Lancet.

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

Earlybreastcancertrialistscol, Early Breast Cancer Trialists' Collaborative Group, 1992, The Lancet.